These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1727921

  • 1. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.
    Hochster HS, Kim KM, Green MD, Mann RB, Neiman RS, Oken MM, Cassileth PA, Stott P, Ritch P, O'Connell MJ.
    J Clin Oncol; 1992 Jan; 10(1):28-32. PubMed ID: 1727921
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
    Morris GJ, Millenson MM, Padavic-Shaller K, Wang H, Rogatko A, Clyde J, Boyd RL, Yeslow G, Halbherr T, Schilder RJ, Smith MR.
    Haematologica; 2004 Dec; 89(12):1484-91. PubMed ID: 15590399
    [Abstract] [Full Text] [Related]

  • 3. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group.
    Hiddemann W, Unterhalt M, Pott C, Wörmann B, Sandford D, Freund M, Engert A, Gassmann W, Holtkamp W, Seufert J.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):28-31. PubMed ID: 8235693
    [Abstract] [Full Text] [Related]

  • 4. Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group.
    Hochster HS, Oken MM, Winter JN, Gordon LI, Raphael BG, Bennett JM, Cassileth PA.
    J Clin Oncol; 2000 Mar; 18(5):987-94. PubMed ID: 10694548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
    Klasa RJ, Meyer RM, Shustik C, Sawka CA, Smith A, Guévin R, Maksymiuk A, Rubinger M, Samosh M, Laplante S, Grenier JF.
    J Clin Oncol; 2002 Dec 15; 20(24):4649-54. PubMed ID: 12488409
    [Abstract] [Full Text] [Related]

  • 7. [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
    Lü SQ, Yang JM, Song XM, Chen L, Zhang WP, Ni X, Xu XQ, Wang JM.
    Zhonghua Zhong Liu Za Zhi; 2007 Sep 15; 29(9):710-2. PubMed ID: 18246806
    [Abstract] [Full Text] [Related]

  • 8. Fludarabine in low-grade lymphoma.
    Pigaditou A, Rohatiner AZ, Whelan JS, Johnson PW, Ganjoo RK, Rossi A, Norton AJ, Amess J, Lim J, Lister TA.
    Semin Oncol; 1993 Oct 15; 20(5 Suppl 7):24-7. PubMed ID: 8235692
    [Abstract] [Full Text] [Related]

  • 9. Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.
    Dimopoulos MA, Fountzilas G, Papageorgiou E, Kiamouris C, Mantzios G, Anagnostopoulos A, Nicolaides C, Economopoulos T, Hellenic Cooperative Oncology Group.
    Leuk Lymphoma; 2002 Jan 15; 43(1):111-4. PubMed ID: 11908713
    [Abstract] [Full Text] [Related]

  • 10. Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
    Pro B, Hagemeister FB, McLaughlin P, Romaguera J, Rodriguez MA, Cabanillas F, Tiongson LP, Younes A.
    Leuk Lymphoma; 2006 Sep 15; 47(9):1818-21. PubMed ID: 17064994
    [Abstract] [Full Text] [Related]

  • 11. Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma.
    Zinzani PL, Lauria F, Rondelli D, Benfenati D, Raspadori D, Bocchia M, Bendandi M, Gozzetti A, Zaja F, Fanin R.
    Ann Oncol; 1993 Aug 15; 4(7):575-8. PubMed ID: 8363989
    [Abstract] [Full Text] [Related]

  • 12. Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
    Abbasi MR, Sparano JA, Sarta C, Wiernik PH.
    Med Oncol; 2003 Aug 15; 20(1):53-8. PubMed ID: 12665685
    [Abstract] [Full Text] [Related]

  • 13. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
    Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH.
    J Clin Oncol; 2005 Feb 01; 23(4):694-704. PubMed ID: 15681517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fludarabine phosphate therapy of non-Hodgkin's lymphoma.
    Hochster H, Cassileth P.
    Semin Oncol; 1990 Oct 01; 17(5 Suppl 8):63-5. PubMed ID: 1699284
    [Abstract] [Full Text] [Related]

  • 16. Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas.
    Bocchia M, Bigazzi C, Marconcini S, Forconi F, Marotta G, Algeri R, Lauria F.
    Haematologica; 1999 Aug 01; 84(8):716-20. PubMed ID: 10457407
    [Abstract] [Full Text] [Related]

  • 17. Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
    Tondini C, Balzarotti M, Rampinelli I, Valagussa P, Luoni M, De Paoli A, Santoro A, Bonadonna G.
    Ann Oncol; 2000 Feb 01; 11(2):231-3. PubMed ID: 10761763
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
    Zinzani PL, Pulsoni A, Gentilini P, Visani G, Perrotti A, Molinari AL, Guardigni L, Tani M, Villivà N, Stefoni V, Alinari L, Martelli M, Bonifazi F, Pileri S, Tura S, Baccarani M.
    Leuk Lymphoma; 2004 Sep 01; 45(9):1815-9. PubMed ID: 15223641
    [Abstract] [Full Text] [Related]

  • 19. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
    Kay AC, Saven A, Carrera CJ, Carson DA, Thurston D, Beutler E, Piro LD.
    J Clin Oncol; 1992 Mar 01; 10(3):371-7. PubMed ID: 1346801
    [Abstract] [Full Text] [Related]

  • 20. Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.
    Tam CS, Wolf MM, Januszewicz EH, Prince HM, Westerman D, Seymour JF.
    Cancer; 2004 May 15; 100(10):2181-9. PubMed ID: 15139062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.